Attached files

file filename
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER - INFITECH VENTURES INCexhibit31-1.htm
EXCEL - IDEA: XBRL DOCUMENT - INFITECH VENTURES INCFinancial_Report.xls
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER - INFITECH VENTURES INCexhibit32-1.htm

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended October 31, 2012

[   ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to _____

COMMISSION FILE NUMBER 000-51073

INFITECH VENTURES INC.
(Exact name of registrant as specified in its charter)

NEVADA 98-0335119
(State or other jurisdiction of incorporation or organization) (I.R.S Employer Identification No.)
   
20 Lyall Avenue  
Toronto, Ontario, Canada M4E 1V9
(Address of principal executive offices) (Zip Code)

(416) 691-4068
(Registrant's telephone number, including area code)

N/A
(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 [X] Yes     [   ] No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

[X] Yes     [   ] No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [   ] Accelerated filer [   ]
Non-accelerated filer [   ] (Do not check if a smaller reporting company) Smaller reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 

[X] Yes     [   ] No

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date: As of December 13, 2012, the Registrant had 15,128,332 shares of common stock outstanding.


PART I - FINANCIAL INFORMATION

ITEM 1.                FINANCIAL STATEMENTS.

The accompanying unaudited financial statements have been prepared in accordance with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X, and, therefore, do not include all information and footnotes necessary for a complete presentation of financial position, results of operations, cash flows, and stockholders' equity in conformity with generally accepted accounting principles. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature. Operating results for the three months ended October 31, 2012 are not necessarily indicative of the results that can be expected for the year ending July 31, 2013.

As used in this Quarterly Report, the terms "we,” "us,” "our,” and “Infitech” mean Infitech Ventures Inc. unless otherwise indicated. All dollar amounts in this Quarterly Report are in U.S. dollars unless otherwise stated.


 

 

INFITECH VENTURES INC.
(A Development Stage Company)

FINANCIAL STATEMENTS
(Expressed in United States Dollars)
(Unaudited)

October 31, 2012

 

 


INFITECH VENTURES INC.
(A Development Stage Company)
BALANCE SHEETS
(Expressed in United States Dollars)
(Unaudited)
As at

    October 31, 2012     July 31, 2012  
             
ASSETS            
             
Current            
           Cash $  15,149   $  1,400  
           Deferred tax asset less valuation allowance of $346,150   -     -  
             
Total assets $  15,149   $  1,400  
             
LIABILITIES AND STOCKHOLDERS' DEFICIENCY            
             
Current            
           Accounts payable and accrued liabilities $  23,543   $  64,023  
           Accounts payable and accrued liabilities - related party   22,200     21,600  
           Due to related parties (Note 6)   134,236     133,488  
                 Total current liabilities   179,979     219,111  
             
Commitments and Contingency (Note 4)            
             
Stockholders' deficiency            
           Common stock            
                 Authorized 100,000,000 common shares with par value of $0.001            
                 Issued and outstanding 14,961,666 shares 
                      (July 31, 2012 - 14,694,999)
  14,962     14,695  
           Additional paid-in capital   813,298     758,565  
           Subscriptions received   25,000     -  
           Deficit accumulated during the development stage   (1,018,090 )   (990,971 )
           Total stockholders' deficiency   (164,830 )   (217,711 )
             
Total liabilities and stockholders' deficiency $  15,149   $  1,400  

Subsequent Event (Note 10)

The accompanying notes are an integral part of these financial statements.

F-2


INFITECH VENTURES INC.
(A Development Stage Company)
STATEMENTS OF OPERATIONS
(Expressed in United States Dollars)
(Unaudited)

    Period from              
    Inception     Three Months     Three Months  
    October 24, 2000     Ended     Ended  
    to October 31, 2012     October 31, 2012     October 31, 2011  
                   
Expenses                  
     Contributed executive services $  555,000   $  15,000 $     15,000  
     Office   47,605     3,136     5,088  
     Professional fees   369,131     8,310     5,750  
     Rent   27,000     600     600  
     Foreign exchange loss   162     73     4  
     Web-site development   1,692     -     -  
                   
Loss before other items   (1,000,590 )   (27,119 )   (26,442 )
                   
     Write off of patent (Note 4)   (17,500 )   -     -  
                   
Net loss $  (1,018,090 ) $  (27,119 ) $  (26,442 )
                   
Basic and diluted net loss per share       $  (0.00 ) $  (0.00 )
                   
Weighted average number of common shares outstanding         14,718,187     14,594,999  

The accompanying notes are an integral part of these financial statements.

F-3


INFITECH VENTURES INC.
(A Development Stage Company)
STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIENCY)
(Expressed in United States Dollars)
(Unaudited)

                                  Deficit        
                                  Accumulated        
    Common Shares     Additional     Obligation           During the        
                Paid in     to Issue     Share     Development        
    Number     Amount     Capital     Shares     Subscriptions     Stage     Total  
                                           
Balance, October 24, 2000 (date of inception)   -   $  -   $  -   $  -   $  -   $  -   $  -  
                                           
Common stock issued for cash at $0.001
       per share, November 13, 2000
  6,000,000     6,000     -     -     -     -     6,000  
Common stock issued for cash at $0.01 
       per share, February 28, 2001
  6,000,000     6,000     54,000     -     -     -     60,000  
Net loss   -     -     -     -     -     (6,995 )   (6,995 )
                                           
Balance, July 31, 2001   12,000,000     12,000     54,000     -     -     (6,995 )   59,005  
                                           
Net loss   -     -     -     -     -     (3,645 )   (3,645 )
                                           
Balance, July 31, 2002   12,000,000     12,000     54,000     -     -     (10,640 )   55,360  
                                           
Common stock issued for cash at $0.05 
       per share, August 15, 2002
  40,000     40     1,960     -     -     -     2,000  
Common stock issued for cash at $0.05 
       per share, December 31, 2002
  54,000     54     2,646     -     -     -     2,700  
Net loss   -     -     -     -     -     (5,722 )   (5,722 )
                                           
Balance, July 31, 2003   12,094,000     12,094     58,606     -     -     (16,362 )   54,338  
                                           
Contributed executive services   -     -     60,000     -     -     -     60,000  
Obligation to issue shares for patent   -     -     -     7,500           -     7,500  
Net loss   -     -     -     -     -     (78,146 )   (78,146 )
                                           
Balance, July 31, 2004   12,094,000     12,094     118,606     7,500     -     (94,508 )   43,692  
                                           
Contributed executive services   -     -     60,000     -     -     -     60,000  
Shares issued for patent   150,000     150     7,350     (7,500 )   -     -     -  
Share subscriptions                           33,960           33,960  
Net loss   -     -     -     -     -     (139,743 )   (139,743 )
                                           
Balance, July 31, 2005   12,244,000     12,244     185,956     -     33,960     (234,251 )   (2,091 )
                                           
Contributed executive services   -     -     60,000     -     -     -     60,000  
Common stock issued for cash at $0.06 
       per share , October 20, 2005
  601,000     601     35,459     -     (33,960 )   -     2,100  
Net loss   -     -     -     -     -     (98,821 )   (98,821 )
                                           
Balance, July, 31 2006   12,845,000     12,845     281,415     -     -     (333,072 )   (38,812 )
                                           
Contributed executive services   -     -     60,000     -     -     -     60,000  
Net loss   -     -     -     -     -     (122,641 )   (122,641 )
                                           
Balance, July, 31 2007   12,845,000     12,845     341,415     -     -     (455,713 )   (101,453 )
                                           
Common stock issued for cash at $0.06 
       per share, October 26, 2007
  400,000     400     23,600     -     -     -     24,000  
Contributed executive services   -     -     60,000     -     -     -     60,000  
Net loss   -     -     -     -     -     (109,388 )   (109,388 )
                                           
Balance, July 31, 2008   13,245,000     13,245     425,015     -     -     (565,101 )   (126,841 )
                                           
Common stock issued at $0.06 
       per share August 21, 2008
  416,666     417     24,583     -     -     -     25,000  
Common stock issued at $0.06 
       per share, May 11, 2009
  333,333     333     19,667     -     -     -     20,000  
Contributed executive services   -     -     60,000     -     -     -     60,000  
Net Loss   -     -     -     -     -     (96,268 )   (96,268 )
                                           
                                           
Balance, July 31, 2009   13,994,999     13,995     529,265     -     -     (661,369 )   (118,109 )
                                           
Common stock issued at $0.06 
       per share January 21, 2010
  250,000     250     14,750     -     -     -     15,000  
Common stock issued at $0.06 
       per share June 15, 2010
  250,000     250     14,750     -     -     -     15,000  
Contributed executive services               60,000     -     -     -     60,000  
Net Loss                                 (97,206 )   (97,206 )
                                           
                                           
Balance, July 31, 2010   14,494,999     14,495     618,765     -     -     (758,575 )   (125,315 )
                                           
Common stock issued at $0.10 
       per share July 7, 2011
  100,000     100     9,900     -     -     -     10,000  
Contributed executive services   -     -     60,000     -     -           60,000  
Net Loss                                 (105,039 )   (105,039 )
                                           
Balance, July 31, 2011   14,594,999     14,595     688,665     -     -     (863,614 )   (160,354 )
                                           
Common stock issued at $0.10 
       per share February 23, 2012
  100,000     100     9,900                 10,000  
Contributed executive services               60,000                       60,000  
Net Loss   -     -     -     -     -     (127,357 )   (127,357 )
                                           
Balance, July 31, 2012   14,694,999     14,695     758,565     -     -     (990,971 )   (217,711 )
                                           
Common stock issued at $0.15 
       per share October 23, 2012
  266,667     267     39,733                 40,000  
Share subscriptins                           25,000           25,000  
Contributed executive services               15,000                       15,000  
Net Loss                                 (27,119 )   (27,119 )
                                           
Balance, October 31, 2012   14,961,666   $  14,962   $  813,298   $  -   $  25,000   $  (1,018,090 ) $  (164,830 )

The accompanying notes are an integral part of these financial statements.

F-4


INFITECH VENTURES INC.
(A Development Stage Company)
STATEMENTS OF CASH FLOWS
(Expressed in United States Dollars)
(Unaudited)

    Period from              
    Inception     Three Months     Three Months  
    October 24, 2000     Ended     Ended  
    to October 31, 2012     October 31, 2012     October 31, 2011  
                   
                   
CASH FLOWS FROM OPERATING ACTIVITIES                  
         Net loss $  (1,018,090 ) $  (27,119 ) $  (26,442 )
         Items not affecting cash:                  
                     Contributed executive services   555,000     15,000     15,000  
                     Write off of patent   17,500     -     -  
         Changes in non-cash working capital items                  
                     Increase (decrease) in accounts payable and                  
                     accrued liabilities   23,543     (40,480 )   (12,780 )
                     Increase in accounts payable and accrued                  
                     liabilities - related party   22,200     600     600  
         Net cash used in operating activities   (399,847 )   (51,999 )   (23,622 )
                   
CASH FLOWS FROM FINANCING ACTIVITIES                  
         Proceeds from the issuance of common stock   265,760     40,000     -  
         Subscriptions received   25,000     25,000        
         Increase in due to related parties   134,236     748     17,500  
         Net cash provided by financing activities   424,996     65,748     17,500  
                   
CASH FLOWS FROM INVESTMENT ACTIVITIES                  
         Acquisition of patent   (10,000 )   -     -  
         Net cash used in investment activities   (10,000 )   -     -  
                   
Change in cash for the period   15,149     13,749     (6,122 )
                   
Cash, beginning of period   -     1,400     9,122  
                   
Cash, end of period $  15,149   $  15,149   $  3,000  
                   
Cash paid for interest during the period $  -   $  -   $  -  
                   
Cash paid for income taxes during the period $  -   $  -   $  -  

Supplemental Cash Flow Disclosure (Note 7)

The accompanying notes are an integral part of these financial statements.

F-5



INFITECH VENTURES INC.
(A Development Stage Company)
NOTES TO THE FINANCIAL STATEMENTS
(Expressed in United States Dollars)
October 31, 2012
(Unaudited)
 

1.

HISTORY AND ORGANIZATION OF THE COMPANY

   

The Company was incorporated on October 24, 2000 under the Laws of the State of Nevada. The Company intended to develop and market a wax technology relating to the process of solidifying and removing spilled oil on land and water. The Company is considered to be a development stage company as it has not generated revenues from operations.

   

All amounts are stated in United States dollars unless otherwise noted.

   
2.

GOING CONCERN

   

These financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America with the on-going assumption that the Company will be able to realize its assets and discharge its liabilities in the normal course of business. However, certain conditions noted below currently exist which raise substantial doubt about the Company’s ability to continue as a going concern.

   

The operations of the Company have primarily been funded by the issuance of common stock. Continued operations of the Company are dependant on the Company’s ability to complete equity financings or generate profitable operations in the future. Management’s plan in this regard is to secure additional funds through future equity sales. Such sales may not be available or may not be available on reasonable terms.

   

There can be no assurance the Company will be able to continue to raise funds in which case the Company may be unable to meet its obligations. Should the Company be unable to realize economic benefit from its assets and discharge its liabilities in the normal course of business, the net realizable value of assets may be materially less than the amounts recorded on the balance sheets. These financial statements do not include any adjustments to the amounts and classifications of assets and liabilities that might be necessary should the Company be unable to continue as a going concern.

   

The current market conditions and volatility increase the uncertainty of the Company’s ability to continue as a going concern given the need to both curtail expenditures and to raise additional funds. The Company is experiencing, and has experienced, negative operating cash flows. The Company will continue to search for new or alternate sources of financing but anticipates that the current market conditions may impact the ability to source such funds.

   
3.

SIGNIFICANT ACCOUNTING POLICIES

   

The significant accounting policies adopted by the Company are as follows:

   

Generally accepted accounting principles

   

The accompanying unaudited financial statements have been prepared by the Company in conformity with accounting principles generally accepted in the United States of America applicable to interim financial information and with the rules and regulations of the United States Securities and Exchange Commission. Accordingly, certain information and note disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed, or omitted, pursuant to such rules and regulations. In the opinion of Management, the unaudited interim financial statements include all adjustments necessary for the fair presentation of the results of the interim periods presented. All adjustments are of a normal recurring nature, except as otherwise noted below. These financial statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto for the year ended July 31, 2012, included in the Company’s Form 10-K, filed with the Securities and Exchange Commission. The results of operations for the interim periods are not necessarily indicative of the results of operations for any other interim period or for a full fiscal year.

F-6



INFITECH VENTURES INC.
(A Development Stage Company)
NOTES TO THE FINANCIAL STATEMENTS
(Expressed in United States Dollars)
October 31, 2012
(Unaudited)
 

3.

SIGNIFICANT ACCOUNTING POLICIES (cont’d)

   

Use of estimates

   

These financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America. The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from these estimates.

   

Foreign currency translation

   

Transaction amounts denominated in foreign currencies are translated at exchange rates prevailing at transaction dates. Carrying values of monetary assets and liabilities are adjusted at each balance sheet date to reflect the exchange rate at that date. Non-monetary assets and liabilities are translated at the exchange rate on the original transaction date. Gains and losses from restatement of foreign currency monetary assets and liabilities are included in the statements of operations. Revenues and expenses are translated at the rates of exchange prevailing on the dates such items are recognized in the statement of operations.

   

Cash and cash equivalents

   

The Company considers cash held at banks and all highly liquid investments with original maturities of three months or less to be cash and cash equivalents. At October 31 and July 31, 2012, cash and cash equivalents consisted of cash held at banks.

   

Accounting for impairment of long-lived assets and for long-lived assets to be disposed of

   

Long-lived assets to be held and used by the Company are continually reviewed to determine whether any events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable.

   

For long-lived assets to be held and used, the Company bases its evaluation on such impairment indicators as the nature of the assets, the future economic benefit of the assets, any historical or future profitability measurements, as well as other external market conditions or factors that may be present. In the event that facts and circumstances indicate that the carrying amount of an asset may not be recoverable and an estimate of future undiscounted cash flows is less than the carrying amount of an asset, an impairment loss will be recognized.

   

Web-site development costs

   

Web-site development costs are expensed as incurred.

F-7



INFITECH VENTURES INC.
(A Development Stage Company)
NOTES TO THE FINANCIAL STATEMENTS
(Expressed in United States Dollars)
October 31, 2012
(Unaudited)
 

3.

SIGNIFICANT ACCOUNTING POLICIES (cont’d)

     

Contributed executive services

     

The Company is required to report all costs of conducting its business. Accordingly, the Company records the fair value of contributed executive services provided to the Company at no cost as compensation expense, with a corresponding increase to additional paid-in capital, in the year in which the services are provided.

     

For each of the three month periods ended October 31, 2012 and 2011 the Company recorded contributed executive services in the amount of $15,000.

     

Income taxes

     

A deferred tax asset or liability is recorded for all temporary differences between financial and tax reporting and net operating loss carry forwards. Deferred tax expenses (benefit) result from the net change during the period of deferred tax assets and liabilities. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

     

Net loss per share

     

Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share takes into consideration shares of common stock outstanding (computed under basic net loss per share) and potentially dilutive shares of common stock.

     

Recent accounting pronouncements

     

There are no recent accounting pronouncements which are expected to have a material effect on the Company’s financial statements.

     
4.

PATENT APPLICATION AND INTELLECTUAL PROPERTY

     

Pursuant to an agreement dated May 6, 2004, the Company acquired a patent application and intellectual rights to a process to solidify and remove spilled oil on land and water.

     

In consideration for the sale, assignment and transfer of the technology, the Company agreed to:

     
a)

Pay the inventor the sum of $10,000 upon execution of the agreement (paid);

  b)

Issue to the inventor a total of 150,000 shares of common stock upon execution of the agreement (issued); and

  c)

Pay to the inventor a royalty fee in the amount of $0.075 (Cdn $0.10) per pound of the formulation produced by or on behalf of the Company to any subsidiary, affiliate, agent or sub-contractor of the Company as defined in the agreement.

     

During the year ended July 31, 2007, due to the uncertainty of the development of this patent, management wrote off the cost to date in its statement of operations.

F-8



INFITECH VENTURES INC.
(A Development Stage Company)
NOTES TO THE FINANCIAL STATEMENTS
(Expressed in United States Dollars)
October 31, 2012
(Unaudited)
 

5.

CAPITAL STOCK

   

Holders of common stock are entitled to one vote for each share held. There are no restrictions that limit the Company's ability to pay dividends on its common stock. The Company has not declared any dividends since incorporation.

   

On October 23, 2012, the Company issued 266,667 shares of its common stock at $0.15 per share for proceeds totaling $40,000 pursuant to a registered offering of 1,000,000 shares.

   
6.

RELATED PARTY TRANSACTIONS

   

At October 31, 2012, there is $134,236 (July 31, 2012 - $133,488) due to a director and shareholder of the Company. The amounts are unsecured, non-interest bearing and are due on demand. Although these advances are interest free, interest will be imputed and charged to contributed capital. To date, imputed interest is an immaterial amount and has not been recorded through October 31, 2012.

   

For each of the three month periods ended October 31, 2012 and 2011 the Company accrued rent of $600 to a director of the Company. Rent is accrued on a month to month basis. At October 31, 2012 there is $22,200 (July 31, 2012 - $21,600) payable to a related party with respect to rent payable.

   

For each of the three month periods ended October 31, 2012 and 2011 there was $15,000 in contributed executive services recorded in additional paid in capital in relation to services of the Company’s sole director.

   

These transactions were in the normal course of operations and were measured at the exchange value which represents the amount of consideration established and agreed to by the related parties.

   
7.

SUPPLEMENTAL CASH FLOW DISCLOSURE

   

During the three month period ended October 31, 2012, the Company’s sole director contributed $15,000 (October 31, 2011 -$15,000) as executive services which was recorded as additional paid in capital.

   
8.

FINANCIAL INSTRUMENTS

   

The Company’s financial instruments consist of cash, accounts payable and accrued liabilities, accounts payable and accrued liabilities – related party and due to related parties. Unless otherwise noted, it is management’s opinion that the Company is not exposed to significant interest, currency or credit risks arising from these financial instruments. The fair value of these financial instruments approximate their carrying values, unless otherwise noted. Cash is based on level 1 inputs.

   
9.

SEGMENT INFORMATION

   

The Company operates in one reportable segment, being the development of a technology relating to the process of solidifying and removing spilled oil on land and water, primarily in Canada.

F-9



INFITECH VENTURES INC.
(A Development Stage Company)
NOTES TO THE FINANCIAL STATEMENTS
(Expressed in United States Dollars)
October 31, 2012
(Unaudited)
 

10.

SUBSEQUENT EVENT

   

On November 14, 2012, the Company issued 166,666 shares of its common stock at $0.15 per share for proceeds totaling $25,000 pursuant to a registered offering of 1,000,000 shares.

F-10



ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

FORWARD-LOOKING STATEMENTS

Certain statements contained in this Quarterly Report on Form 10-Q constitute "forward-looking statements." These statements, identified by words such as “plan,” "anticipate," "believe," "estimate," "should," "expect" and similar expressions include our expectations and objectives regarding our future financial position, operating results and business strategy. These statements reflect the current views of management with respect to future events and are subject to risks, uncertainties and other factors that may cause our actual results, performance or achievements, or industry results, to be materially different from those described in the forward-looking statements. Such risks and uncertainties include those set forth under the caption “Part II – Item 1A. Risk Factors” and elsewhere in this Quarterly Report. We do not intend to update the forward-looking information to reflect actual results or changes in the factors affecting such forward-looking information. We advise you to carefully review the reports and documents, particularly our Annual Reports, our Quarterly Reports and our Current Reports we file from time to time with the United States Securities and Exchange Commission (the “SEC”). Copies of all of our filings with the SEC may be accessed by visiting the SEC site (http://www.sec.gov) and performing a search of our electronic filings.

INTRODUCTION

The following discussion and analysis summarizes our plan of operation for the next twelve months, our results of operations for the three months ended October 31, 2012, and changes in our financial condition from July 31, 2012. This discussion should be read in conjunction with the Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the fiscal year ended July 31, 2012 filed with the SEC on October 29, 2012.

OVERVIEW

We were incorporated on October 24, 2000 under the laws of the State of Nevada for the purpose of seeking business opportunities with respect to environmental technologies and products.

Our business revolves around the development and marketing of a proprietary technology (the “Wax Technology”) that uses a molten wax compound consisting of paraffin wax and resins to control, clean and remediate oil and other liquid fuel spills on land and water. In addition, as part of our long-term business plan, we intend to pursue business opportunities in wastewater treatment solutions.

We continue to require additional financing if we are to continue as a going concern and to finance our business operations. As of October 31, 2012, we had cash on hand of $15,149. If we are not able to acquire sufficient financing in the near future, our business could fail and investors could lose their investment.

PLAN OF OPERATION

Our current plan of operation calls for us to spend approximately $750,000 over the next twelve months in pursuing our plan of operation subject to obtaining sufficient financing. This amount is significantly greater than the total amount of financing that we have been able to obtain to date. There exists a substantial doubt that we will be able to obtain sufficient financing to complete this plan of operation in the current economic climate.

If we are able to obtain sufficient financing, our plan of operation for the next twelve months will involve the following:

1.

Product Formulation and Testing: We intend to continue to develop, refine and test various formulations of our Wax Technology to develop a number of final products for application on various types of oils and fuels and locations. During this phase of our business plan, we expect that the majority of our activities will involve laboratory research and development and field testing of various formulations. During this stage of our development we will also work to develop application equipment designed to meet the needs of specific customers. We anticipate spending approximately $75,000 to complete the product formulation and testing phase of our plan of operation. If we are able to obtain sufficient financing, of which there is no assurance, we expect that it will take us approximately six months to complete this phase of our plan of operation.

3



2.

Product Refinement, Market Development and Regulatory Approvals: Once we have completed the development of our anticipated products, we intend to focus our efforts on developing the market for those products. We will refine our marketing and sales program for each of the products depending upon the results our product development efforts. We expect that this phase of our plan will involve the following:

     
(i)

We will analyze our business model based on the anticipated costs of manufacturing our products and will determine the price of our products based upon that analysis and upon our analysis of market demand.

     
(ii)

We will conduct field tests of our product formulations and applicator equipment in an attempt to further refine them prior to marketing.

     
(iii)

Subject to our obtaining additional financing, of which there is no assurance, we intend to submit our products to Environment Canada and the US Environmental Protection Agency and other regulatory bodies in an attempt to obtain their approval for our products.

     

We anticipate spending approximately $75,000 to complete this phase of our plan of operation. We do not anticipate beginning this stage of our plan of operation until we have completed the product formulation and testing phase. We anticipate that this phase of our business will take approximately six to twelve months to complete and we do not anticipate making any significant sales or generating any significant revenues until this phase of our plan of operation is complete.

     
3.

Production and Manufacturing: Once we have completed the market development stage of our plan, we anticipate that we will begin to produce and manufacture our products. We expect to expend approximately $325,000 over a twelve month period in producing and manufacturing our planned products and the applicator equipment to be used for dispensing those products. Production and manufacturing costs are expected to include the cost of raw materials, including paraffin wax, blending of the wax and other raw materials and packaging.

     
4.

Marketing: We also anticipate that, once we have completed the market development stage of our plan, we will begin to aggressively market our products. We intend to develop marketing literature, demonstration videos and digital media, enhance our internet capabilities, visit potential customers and conduct demonstrations and present exhibits at tradeshows. We expect to spend approximately $100,000 on marketing activities over a twelve month period.

In addition, we anticipate spending approximately $75,000 on legal, patent and other professional fees and approximately $100,000 on general administrative expenses and salaries for any sales and/or administrative personnel that we may hire.

Although we will explore opportunities in wastewater treatment as they present themselves, we do not expect to actively pursue opportunities in this area over the next twelve months and we intend to focus our available resources on developing and marketing the Wax Technology.

Financing Requirements

Currently, we do not have sufficient financial resources to complete our plan of operation for the next twelve months. As such, our ability to complete our plan of operation is dependent upon our ability to obtain additional financing in the near term.

4


To date, we have relied on short term loans from our sole executive officer and director and private placement sales of our equity securities in order to finance our ongoing activities and to meet our outstanding financial obligations. There is no assurance that we will be able to continue to obtain financing from these sources in the future. Our sole executive officer and director could refuse to provide us with any additional financing and we may not be able to find suitable investors willing to purchase our equity securities. If we are unable to obtain financing, our business could fail and shareholders could lose some or all of their investment.

On February 23, 2012, we sold 100,000 shares of our common stock at a price of $0.10 per share for proceeds of $10,000. This private placement was completed pursuant to the provisions of Regulation S promulgated under the United States Securities Act, as amended. The purchaser represented that he was not a “US person” as that term is defined in Rule 902(k) of Regulation S, and that he was not acquiring our securities for the account or benefit of a US person.

On May 30, 2012, we received notice of effectiveness of our Post-Effective Amendment No.1 to our Registration Statement (No.333 – 170648) on Form S-1 registering the sale up to 1,000,000 shares of our common stock at a price of $0.15 per share (the “Direct Offering”) and the resale of 8,494,999 shares of our common stock held by current shareholders (the “Resale Offering”). We will not receive any proceeds from the Resale Offering. Proceeds received under the Direct Offering will not be sufficient to allow us to complete our Plan of Operation. On October 23, 2012, we sold 266,667 shares and on November 14, 2012, we sold 166,666 shares under the Direct Offering at a price of $0.15 per share. The proceeds from these sales will be used for working capital purposes. There is no assurance that we will sell any additional shares under the Direct Offering.

RESULTS OF OPERATIONS

Three Months Summary                  
    Three Months Ended October 31,     Percentage  
    2012     2011     Increase / (Decrease)  
 Revenue $  -   $  -       n/a  
 Expenses   (27,119 )   (26,442 )   2.6%  
 Net Loss $  (27,119 ) $  (26,442 )   2.6%  

Revenues

We have not earned any revenues to date and we do not anticipate earning revenue until we have completed commercial development of products incorporating our Wax Technology. We are presently in the development stage of our business and we can provide no assurance that we will be able to complete commercial development or successfully sell or license products incorporating our Wax Technology once development is complete

Operating Costs and Expenses

Our operating expenses for the three months ended October 31, 2012 and 2011 consisted of the following:

    Three Months Ended October 31,     Percentage  
    2012     2011     Increase / (Decrease)  
Contributed Executive Services $  15,000   $  15,000     n/a  
Office   3,136     5,088     (38.4)%
Professional Fees   8,310     5,750     44.5%  
Rent   600     600     n/a  
Foreign Exchange Loss   73     4     1725.0%  
Total Operating Expenses $  27,119   $  26,442     2.6%  

5


During the three months ended October 31, 2012, our operating expenses primarily consisted of accounting expenses, legal expenses and office administration expenses. Operating expenses for the three months ended October 31, 2012 increased slightly as a result of increased professional fees and foreign exchange loss. The increase was partially offset by a decrease in office administration expenses.

We are required to report all costs of conducting our business. As such, we have recorded as an expense the fair market value of contributed executive services provided to us at no cost. We recorded contributed executive services of $5,000 per month. These services are provided to us at no charge and a corresponding increase in additional paid-in capital has been recorded.

If we are able to obtain sufficient financing to proceed with our plan of operation, of which there is no assurance, we expect that our expenses will increase significantly as we engage in product and business development activities.

LIQUIDITY AND CAPITAL RESOURCES

Working Capital                  
                Percentage  
    At October 31, 2012     At July 31, 2012     Increase / (Decrease)  
Current Assets $  15,149   $  1,400     982.1%  
Current Liabilities   (179,979 )   (219,111 )   (17.9)%  
Working Capital Deficit $  (164,830 ) $  (217,711 )   (24.3)%  

Cash Flows            
    Three Months Ended October 31,  
    2012     2011  
Cash Flows (Used In) Operating Activities $  (51,999 ) $  (23,622 )
Cash Flows (Used In) Investing Activities   -     -  
Cash Flows From Financing Activities   65,748     17,500  
Net Increase (Decrease) In Cash During Period $  13,749   $  (6,122 )

Our only sources of financing for the fiscal quarter ended October 31, 2012 was proceeds from the issuance of our common stock, advance subscriptions for shares of our common stock and an increase in amounts due to related parties. Subsequent to our fiscal quarter ended October 31, 2012 we issued shares of our common stock to the advance subscribers.

Our plan of operation calls for us to spend significantly more than our current capital resources or the amount of financing that we have been able to obtain to date. As such, there is a substantial doubt that we will be able to raise significant financing to complete our stated plan of operation. Any substantial financing that we are able to obtain is expected to be in the form of equity financing.

During the three months ended October 31, 2011, we received loans of $17,500 from Paul G. Daly, our sole director and executive officer. The loans are unsecured, non-interest bearing and due on demand.

On May 30, 2012, we received notice of effectiveness of our Post-Effective Amendment No.1 to our Registration Statement (No.333 – 170648) on Form S-1 registering the sale up to 1,000,000 shares of our common stock at a price of $0.15 per share (the “Direct Offering”) and the resale of 8,494,999 shares of our common stock held by current shareholders (the “Resale Offering”). We will not receive any proceeds from the Resale Offering. Proceeds received under the Direct Offering will not be sufficient to allow us to complete our Plan of Operation. On October 23, 2012, we sold 266,667 shares and on November 14, 2012, we sold 166,666 shares under the Direct Offering at a price of $0.15 per share. The proceeds from these sales will be used for working capital purposes. There is no assurance that we will sell any additional shares under the Direct Offering.

6


OFF-BALANCE SHEET ARRANGEMENTS

We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to stockholders.

CRITICAL ACCOUNTING POLICIES

The financial statements presented with this Quarterly Report have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information. These financial statements do not include all information and footnote disclosures required for an annual set of financial statements prepared under United States generally accepted accounting principles. In the opinion of our management, all adjustments (consisting solely of normal recurring accruals) considered necessary for a fair presentation of the financial position, results of operations and cash flows as at October 31, 2012, and for all periods presented in the attached financial statements, have been included. Interim results for the three months ended October 31, 2012 are not necessarily indicative of the results that may be expected for the fiscal year as a whole.

We have identified certain accounting policies, described below, that are most important to the portrayal of our current financial condition and results of operations. Our significant accounting policies are disclosed in the notes to the interim financial statements included with this Quarterly Report.

Foreign Currency Translation

Transaction amounts denominated in foreign currencies are translated at exchange rates prevailing at transaction dates. Carrying values of monetary assets and liabilities are adjusted at each balance sheet date to reflect the exchange rate at that date. Non-monetary assets and liabilities are translated at the exchange rate on the original transaction date. Gains and losses from restatement of foreign currency monetary assets and liabilities are included in the statements of operations. Revenues and expenses are translated at the rates of exchange prevailing on the dates such items are recognized in the statement of operations.

Contributed Executive Services

We are required to report all costs of conducting our business. Accordingly, we record the fair value of contributed executive services provided to us at no cost as compensation expense, with a corresponding increase to additional paid-in capital, in the year in which the services are provided.

ITEM 3.                QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Not Applicable.

ITEM 4.                CONTROLS AND PROCEDURES.

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures as required by Exchange Act Rules 13a-15(e) and 15(d)-15(e) as of October 31, 2012 (“Evaluation Date”). Based upon that evaluation our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of the Evaluation Date as a result of the material weaknesses in internal control over financial reporting discussed in our Annual Report on Form 10-K for the year ended July 31, 2012 (the “2012 Annual Report”).

7


Notwithstanding the assessment that our internal controls over financial reporting were not effective and that there were material weaknesses as identified in our 2012 Annual Report, we believe that our financial statements contained in our Quarterly Report on Form 10-Q for the fiscal quarter ended October 31, 2012 report fairly present our financial condition, results of operations and cash flows in all material respects.

Changes in Internal Controls

There were no changes in our internal control over financial reporting during the fiscal quarter ended October 31, 2012 that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

8


PART II - OTHER INFORMATION

ITEM 1.                LEGAL PROCEEDINGS.

We are not a party to any other legal proceedings and, to our knowledge; no other legal proceedings are pending, threatened or contemplated.

ITEM 1A.              RISK FACTORS.

The following are some of the important factors that could affect our financial performance or could cause actual results to differ materially from estimates contained in our forward-looking statements. We may encounter risks in addition to those described below. Additional risks and uncertainties not currently known to us, or that we currently deem to be immaterial, may also impair or adversely affect our business, financial condition or results of operation.

Need For Financing

We do not currently have the financial resources to complete our plan of operation for the next twelve months. We anticipate that we will require financing in the amount of $750,000 in order to fund our plan of operation over the next twelve months. We presently do not have any sufficient financing arrangements in place and there is no assurance that we will be able to obtain sufficient financing on terms acceptable to us or at all. If further financing is not available, our ability to meet our financial obligations and pursue our plan of operation will be substantially limited. If we are not able to meet our financial obligations as they come due, our business could fail and investors could lose a substantial portion or all of their investment.

On May 30, 2012, we received notice of effectiveness of our Post-Effective Amendment No.1 to our Registration Statement (No.333 – 170648) on Form S-1 registering the sale up to 1,000,000 shares of our common stock at a price of $0.15 per share (the “Direct Offering”) and the resale of 8,494,999 shares of our common stock held by current shareholders (the “Resale Offering”). We will not receive any proceeds from the Resale Offering. Proceeds received under the Direct Offering will not be sufficient to allow us to complete our Plan of Operation. On October 23, 2012, we sold 266,667 shares and on November 14, 2012, we sold 166,666 shares under the Direct Offering at a price of $0.15 per share. The proceeds from these sales will be used for working capital purposes. There is no assurance that we will sell any additional shares under the Direct Offering.

Limited Operating History, Risks Of A New Business Venture

We were incorporated on October 24, 2000 and, prior to our acquisition of the Wax Technology, we had been involved primarily in organizational activities and in seeking business opportunities related to environmental technologies and products. We have not earned any revenues to date.

Potential investors should be aware of the difficulties normally encountered by a new enterprise and the high rate of failure of such enterprises. The potential for future success must be considered in light of the problems, expenses, difficulties complications and delays encountered in connection with the development of a business in the area in which we intend to operate and in connection with the formation and commencement of operations of a new business in general. These include, but are not limited to, unanticipated problems relating to research and development programs, marketing, approvals by government agencies, competition and additional costs and expenses that may exceed current estimates. There is no history upon which to base any assumption as to the likelihood that our business will prove successful, and there can be no assurance that we will generate any operating revenues or ever achieve profitable operations.

9


Our Operations Will Be Subject To Extensive Government Regulations

Our operations will be subject to extensive government regulations in the United States, Canada and in other countries in which we may operate. In order to sell our anticipated products, we may be required to obtain a number of regulatory approvals at the federal, state and local level, including the approval of the U.S. Environmental Protection Agency and Environment Canada. We may incur material costs or liabilities in obtaining such approvals and/or complying with applicable laws and regulations. Furthermore, our potential customers may be required to comply with numerous laws and regulations when engaging in environmental remediation activities. There can be no assurance that we will be able to successfully comply with all present or future government regulations. An inability to obtain necessary regulatory approvals or the imposition of onerous conditions on the use of our anticipated products will have a materially adverse effect on us, our business and our financial condition.

Our Business Operations, Assets and Personnel Are Located Outside The United States

Although we are incorporated in the United States, all of our current operating activities are conducted in, and all of our assets and personnel are located in, Canada. As such, investors in our securities may experience difficulty in enforcing judgments or liabilities against the Company or our personnel under United States securities laws.

Our corporate headquarters are located at 20 Lyall Avenue, Toronto, Ontario, Canada, M4E 1V9. As we are a Nevada corporation, we are required to maintain a resident agent in the State of Nevada for the purpose of receiving service of process. Under Section 78.090 of the Nevada Revised Statutes, all legal process and any demand or notice authorized by law to be served upon the Company may be served upon our resident agent in Nevada. Our resident agent for this purpose is Camlex Management (Nevada) Inc. of 8275 S. Eastern Avenue, Suite 200, Las Vegas, Nevada, 89123.

As a Nevada corporation, we are subject to the laws of the United States, including the federal securities laws of the United States, and to the jurisdiction of United States courts. As such, investors may bring proceedings against us, and enforce judgments obtained against us, in United States courts.

Generally, original actions to enforce liabilities under United States federal securities laws may not be brought in a Canadian court. Such actions must be brought in a court in the United States with applicable jurisdiction. Persons obtaining judgments against us in United States courts, including judgments obtained under United States federal securities laws, will then be required to bring an application in a Canadian court to enforce such judgments in Canada.

Competition Is Intense And We May Be Unable To Achieve Market Acceptance

The business environment in which we intend to operate is highly competitive. Currently, there exist a number of established methods, products and technologies used to control, clean and remediate oil spills and we expect to experience competition from a number of established companies involved in the environmental remediation industry. Certain of our potential competitors will have greater technical, financial, marketing, sales and other resources than us.

In addition, while the environmental remediation industry is a mature one, there is no established market for products utilizing our Wax Technology. We are unable to provide assurances that our target customers and markets will accept our technologies or will purchase our products and services in sufficient quantities to achieve profitability. If a significant market fails to develop or develops more slowly than we anticipate, we may be unable to recover the losses incurred to develop products and we may be unable to meet our operational expenses. Acceptance of our anticipated products by environmental remediation firms and other organizations will depend upon a number of factors, including the cost competitiveness of our products, customer reluctance to try new products or services, regulatory requirements or the emergence of more competitive or effective products.

10


Asserting And Defending Intellectual Property Rights May Impact The Results Of Our Operations

We had applied for a patent from the CIPO, however, we did not receive a final grant of patent from the CIPO, and we have decided to abandon our patent application at this time. As patent applications are publicly available documents, competitors may be able to copy the formulations set out in our patent application. Due to our limited financial resources, we do not expect to apply for patent protection for any new developments that we make to the Wax Technology. As a result, in order to protect future developments, we will need to maintain the secrecy of our formulations and the methods we use. If we are unable to maintain the secrecy of those developments, then competitors may be able to copy our formulations and methodology, which would have a material adverse effect on our business.

Dependence On Key Personnel

Our success will largely depend on the performance of our directors and officers and our key consultants. Our success will also depend on our ability to attract and retain highly skilled technical, research, management, regulatory compliance, sales and marketing personnel. Competition for such personnel is intense. The loss of the services of such personnel or the inability to attract and retain other key personnel could impair the development of our business, operating results and financial condition.

Our Stock is a Penny Stock

Because our stock is a penny stock, shareholders will be more limited in their ability to sell their stock. The SEC has adopted rules that regulate broker-dealer practices in connection with transactions in penny stocks. Penny stocks are generally equity securities with a price of less than $5.00, other than securities registered on certain national securities exchanges or quoted on the Nasdaq system, provided that current price and volume information with respect to transactions in such securities is provided by the exchange or quotation system. Because our securities constitute “penny stocks” within the meaning of the rules, the rules apply to us and to our securities. The rules may further affect the ability of owners of shares to sell our securities in any market that might develop for them. As long as the trading price of our common stock is less than $5.00 per share, the common stock will be subject to Rule 15g-9 under the Exchange Act. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock, to deliver a standardized risk disclosure document prepared by the SEC, that:

  1.

contains a description of the nature and level of risk in the market for penny stocks in both public offerings and secondary trading;

     
  2.

contains a description of the broker’s or dealer’s duties to the customer and of the rights and remedies available to the customer with respect to a violation to such duties or other requirements of securities laws;

     
  3.

contains a brief, clear, narrative description of a dealer market, including bid and ask prices for penny stocks and the significance of the spread between the bid and ask price;

     
  4.

contains a toll-free telephone number for inquiries on disciplinary actions;

     
  5.

defines significant terms in the disclosure document or in the conduct of trading in penny stocks; and

     
  6.

contains such other information and is in such form, including language, type, size and format, as the SEC shall require by rule or regulation.

The broker-dealer also must provide, prior to effecting any transaction in a penny stock, the customer with: (a) bid and offer quotations for the penny stock; (b) the compensation of the broker-dealer and its salesperson in the transaction; (c) the number of shares to which such bid and ask prices apply, or other comparable information relating to the depth and liquidity of the market for such stock; and (d) a monthly account statements showing the market value of each penny stock held in the customer’s account. In addition, the penny stock rules require that prior to a transaction in a penny stock not otherwise exempt from those rules; the broker-dealer must make a special written determination that the penny stock is a suitable investment for the purchaser and receive the purchaser’s written acknowledgment of the receipt of a risk disclosure statement, a written agreement to transactions involving penny stocks, and a signed and dated copy of a written suitably statement. These disclosure requirements may have the effect of reducing the trading activity in the secondary market for our stock.

11


ITEM 2.                UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

None.

ITEM 3.                DEFAULTS UPON SENIOR SECURITIES.

None.

ITEM 4.                MINE SAFETY DISCLOSURES.

None.

ITEM 5.                OTHER INFORMATION.

None.

ITEM 6.                EXHIBITS.

The following exhibits are either provided with this Quarterly Report or are incorporated herein by reference:

Exhibit    
Number   Description of Exhibit
3.1   Articles of Incorporation.(1)
3.2   Bylaws.(1)
4.1  

Specimen Common Stock Certificate.(1)

10.1

Technology Transfer Agreement dated May 6, 2004 between William Ernest Nelson and Infitech Ventures Inc.(1)

10.2  

Receipt and Acknowledgement of William Ernest Nelson dated February 5, 2005.(1)

10.3  

Promissory Note dated April 27, 2005 for $9,000 issued by the Company to Paul G. Daly.(3)

10.4  

Promissory Note dated May 6, 2005 for $11,500 issued by the Company to Paul G. Daly.(3)

10.5

Promissory Note dated October 12, 2006 for CDN$500 issued by the Company to Paul G. Daly.(3)

10.6

Promissory Note dated December 1, 2006 for CDN$700 issued by the Company to Paul G. Daly.(3)

10.7

Promissory Note dated March 5, 2007 for CDN$400.00 issued by the Company to Paul G. Daly.(3)

10.8  

Promissory Note dated June 4, 2007 for $6,000 issued by the Company to Paul G. Daly.(4)

10.9  

Promissory Note dated July 19, 2007 for $6,095 issued by the Company to Paul G. Daly.(4)

10.10

Promissory Note dated August 24, 2007 for $5,000 issued by the Company to Paul G. Daly.(4)

10.11

Promissory Note dated September 24, 2007 for $20,000 issued by the Company to Paul G. Daly.(4)

10.12  

Promissory Note dated March 6, 2008 for $5,000 issued by the Company to Paul G. Daly.(5)

10.13  

Promissory Note dated May 9, 2008 for $11,375 issued by the Company to Paul G. Daly.(6)

12



 Exhibit    
Number   Description of Exhibit
10.14

Promissory Note dated September 30, 2009 for $800.00 issued by the Company to Paul G. Daly.(7)

10.15

Promissory Note dated December 3, 2009 for $800.00 issued by the Company to Paul G. Daly.(8)

10.16

Promissory Note dated December 14, 2010 for $2000.00 issued by the Company to Paul G. Daly.(9)

10.17

Promissory Note dated February 8, 2011 for $10,000.00 issued by the Company to Paul G. Daly.(9)

10.18

Promissory Note dated June 9, 2011 for $10,000.00 issued by the Company to Paul G. Daly.(10)

10.19

Promissory Note dated October 7, 2011 for $7,500.00 issued by the Company to Paul G. Daly(11)

10.20

Promissory Note dated October 27, 2011 for $10,000.00 issued by the Company to Paul G. Daly(11)

10.21

Promissory Note dated November 24, 2011 for $10,000.00 issued by the Company to Paul G. Daly(12)

10.22

Promissory Note dated February 27, 2012 for CDN $2,000.00 issued by the Company to Paul G. Daly(13)

10.23

Promissory Note dated May 11, 2012 for CDN $1,000.00 issued by the Company to Paul G. Daly(14)

10.24

Promissory Note dated May 11, 2012 for $1,000.00 issued by the Company to Paul G. Daly(14)

10.25

Promissory Note dated June 29, 2012 for CDN $2,500.00 issued by the Company to Paul G. Daly(14)

14.1  

Code of Ethics.(2)

31.1

Certification of Chief Executive Officer and Chief Financial Officer as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1

Certification of Chief Executive Officer and Chief Financial Officer as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS  

XBRL Instance Document.

101.SCH  

XBRL Taxonomy Extension Schema.

101.CAL  

XBRL Taxonomy Extension Calculation Linkbase.

101.DEF  

XBRL Taxonomy Extension Definition Linkbase.

101.LAB  

XBRL Taxonomy Extension Label Linkbase.

101.PRE  

XBRL Taxonomy Extension Presentation Linkbase.

Notes:

(1)

Filed as an exhibit to our Registration Statement on Form 10-SB originally filed with the SEC on February 15, 2005, as amended.

(2)

Filed as an exhibit to our Annual Report on Form 10-KSB filed with the SEC on November 9, 2005.

(3)

Filed as an exhibit to our Quarterly Report on Form 10-QSB filed with the SEC on March 23, 2007.

(4)

Filed as an exhibit to our Annual Report on Form 10-KSB filed with the SEC on November 2, 2007.

(5)

Filed as an exhibit to our Quarterly Report on Form 10-QSB filed with the SEC on March 14, 2008.

(6)

Filed as an exhibit to our Amended Quarterly Report on Form 10-QSB/A filed with the SEC on October 23, 2008.

(7)

Filed as an exhibit to our Quarterly Report on Form 10-Q filed with the SEC on December 14, 2009.

(8)

Filed as an exhibit to our Quarterly Report on Form 10-Q filed with the SEC on March 16, 2010.

(9)

Filed as an exhibit to our Quarterly Report on Form 10-Q filed with the SEC on March 17, 2011.

(10)

Filed as an exhibit to our Annual Report on Form 10-K filed with the SEC on October 31, 2011.

(11)

Filed as an exhibit to our Quarterly Report on Form 10-Q filed with the SEC on December 15, 2011.

(12)

Filed as an exhibit to our Quarterly Report on Form 10-Q filed with the SEC on March 14, 2011.

(13)

Filed as an exhibit to our Quarterly Report on Form 10-Q filed with the SEC on June 14, 2012.

(14)

Filed as an exhibit to our Annual Report on Form 10-K filed with the SEC on October 29, 2012.

13


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

        INFITECH VENTURES INC.
         
         
         
Date: December 14, 2012   By: /s/ Paul G. Daly
        PAUL G. DALY
        Chief Executive Officer, Chief Financial Officer
        President, Secretary and Treasurer
        (Principal Executive Officer, Principal Financial Officer
        and Principal Accounting Officer)

14